These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9865334)

  • 21. Simple therapy for cardiac concordant xenotransplantation: only 1 week of DSG administration with suppression of t-cell reactions.
    Kubota S; Miyatake T; Miyazaki K; Watanabe T; Mafune N; Watanabe S; Abe K; Murashita T; Yasuda K
    Transplant Proc; 2000 Aug; 32(5):1020. PubMed ID: 10936329
    [No Abstract]   [Full Text] [Related]  

  • 22. FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-cell infiltration into grafts.
    Yanagawa Y; Hoshino Y; Kataoka H; Kawaguchi T; Ohtsuki M; Sugahara K; Chiba K
    Transplant Proc; 1999; 31(1-2):1227-9. PubMed ID: 10083548
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
    Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
    Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.
    Suzuki S; Enosawa S; Kakefuda T; Amemiya H; Hoshino Y; Chiba K
    Transplant Proc; 1996 Jun; 28(3):1375-6. PubMed ID: 8658701
    [No Abstract]   [Full Text] [Related]  

  • 25. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescuing acute rejection of rat cardiac allografts with FTY720.
    Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
    [No Abstract]   [Full Text] [Related]  

  • 27. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
    Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
    Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons.
    Quesniaux V; Fullard L; Arendse H; Davison G; Markgraaff N; Auer R; Ehrhart F; Kraus G; Schuurman HJ
    Transpl Immunol; 1999 Sep; 7(3):149-57. PubMed ID: 10608298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FTY720 in combination with CsA inhibits islet xenograft rejection: a study in the pig-to-rat model.
    Zhang J; Song Z; Wijkström M; Bari S; Sundberg B; Nava S; Groth CG; Korsgren O; Wennberg L
    Transplant Proc; 2000 Aug; 32(5):1017. PubMed ID: 10936327
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting.
    Kita Y; Li XK; Funeshima N; Enosawa S; Tamura A; Hayashi S; Suzuki K; Kazui T; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2787-8. PubMed ID: 10578291
    [No Abstract]   [Full Text] [Related]  

  • 32. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
    Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
    Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
    Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK
    Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation.
    Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P
    Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 37. Late xenograft rejection: comparison between liver and heart xenografts under low-dose tacrolimus.
    Molleví DG; Morell Ginestà M; Ribas Y; Mestre M; Vidal A; Serano T; Figueras J; Jaurrieta J
    Transplant Proc; 2002 Feb; 34(1):111-2. PubMed ID: 11959212
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
    Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
    Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
    Yuzawa K; Stephkowski SM; Wang M; Kahan BD
    Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.